Media presence is a key part of making society aware of developments in biotechnology and its benefits. AseBio makes this platform available to members so they can share their press releases, alongside those the association posts regularly. If you are a journalist interested in learning more about the biotechnology sector, contact us at AseBio.
Promega PBMC ADCC Bioassay combines physiologically representative primary cells with reliable quantitative readout technology
- The compound is currently in Phase II
- Now has orphan designation in both U.S. and EU
Natac is looking for sales representatives
Oncoheroes Biosciences is proud to begin 2021 by announcing an investment by the Catalytic Impact Foundation (CIF). CIF is a non-profit, 501(c)(3) organization, committed to helping innovative, early-stage companies to overcome the “valley of death”, a funding gap that start-ups often face between receiving grants for research and for-profit investments.
Primarily used in the Flavours & Fragrances (F&F) and Fine Chemicals industries, alcohol dehydrogenase is type of enzyme that helps convert alcohols into ketones/aldehydes with exceptionally high stereoselectivity.
The company will present recent clinical developments at the H.C. Wainwright Bioconnect, will participate in the 10th Annual Corporate Access Event of LifeSci Advisors 2021, in the open house of Edison-Global Healthcare 2021 and in ACCESS CHINA Forum @JPM Week 2021. All events will be held virtually for three weeks consecutive in January
Goal is to characterize the neuropsychiatric symptoms of patients harboring disease-causing SETD1A gene mutations. Also includes fundamental research in preclinical SETD1A models
The European Union has awarded a grant of 25.5€ million for the Accelerating Research and Innovation for Advanced Therapies (ARDAT) project.